Comparison of Oliceridine to Remifentanil for Optimal Analgesia in Mechanical Ventilation (CO-ROAM): Study Protocol for a Multicenter Randomized Controlled Trial
Pain and Therapy · 2024-12 · 13 (6) · 1695-1704
DOI: 10.1007/s40122-024-00669-4 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pain and Therapy, online erschienen am 18.10.2024. Verfasst von Jing-Chao Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science …. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Beatmung und Weaning
Abstract (Originalsprache)
INTRODUCTION: Critically ill patients often endure pain, a distressing experience that can trigger diverse pathophysiological consequences. While remifentanil, with its rapid kinetics, is commonly used for analgesia in intensive care units (ICU), it frequently leads to opioid-related adverse effects. A promising alternative has emerged in oliceridine, a novel G protein-biased μ-opioid receptor agonist. This new drug offers the potential for effective pain relief with fewer side effects. However, its efficacy and safety profile in mechanically ventilated ICU patients remain to be fully elucidated. METHODS: This is a multicenter, prospective, randomized, single-blind, active-controlled trial conducted across 24 ICUs in China. A total of 292 mechanically ventilated patients requiring analgesia and sedation will be randomly assigned in a 1:1 ratio to either the oliceridine or remifentanil group. The oliceridine group will receive oliceridine (2-20 μg/kg/h), while the remifentanil group will receive remifentanil (1.5-12 μg/kg/h). Both groups will receive propofol for sedation if necessary. The target for analgesia is Critical-Care Pain Observation Tool (CPOT) < 3, and for sedation is Richmond Agitation-Sedation Scale (RASS) - 2 to 0. PLANNED OUTCOMES: The primary outcome will be the percentage of time within target analgesia during study drug administration. Secondary outcomes will include gastrointestinal dysfunction, respiratory depression, sedative usage, mechanical ventilation duration, ICU stay length, extubation failure rate, etc. TRIAL REGISTRATION: NCT06454292. Registered on June 11, 2024.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Critical Care Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. panchun1982@gmail.com.
- Department of Critical Care Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. hxbcool1970@163.com.
Zitieren
APA
Luo, J. C., Lu, S., Fu, X. L., Shen, J., He, H. L., Pan, C., & Huang, X. B. (2024). Comparison of Oliceridine to Remifentanil for Optimal Analgesia in Mechanical Ventilation (CO-ROAM): Study Protocol for a Multicenter Randomized Controlled Trial. Pain and Therapy, 13(6), 1695-1704. https://doi.org/10.1007/s40122-024-00669-4
Vancouver
Luo JC, Lu S, Fu XL, Shen J, He HL, Pan C, et al. Comparison of Oliceridine to Remifentanil for Optimal Analgesia in Mechanical Ventilation (CO-ROAM): Study Protocol for a Multicenter Randomized Controlled Trial. Pain and Therapy. 2024;13(6):1695-1704. doi:10.1007/s40122-024-00669-4
BibTeX
@article{Luo2024,
author = {Luo, Jing-Chao and Lu, Sen and Fu, Xi-Liang and Shen, Jun and He, Hong-Li and Pan, Chun and Huang, Xiao-Bo},
title = {Comparison of Oliceridine to Remifentanil for Optimal Analgesia in Mechanical Ventilation (CO-ROAM): Study Protocol for a Multicenter Randomized Controlled Trial},
journal = {Pain and Therapy},
year = {2024},
volume = {13},
number = {6},
pages = {1695--1704},
doi = {10.1007/s40122-024-00669-4}
}
EUVIMED